Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Ireland

European Innovation Council · Running

DUO 4 ALL Duo 4 All

Coordinator
Croivalve Limited, Ireland
Runs
1 August 2025 to 31 January 2027
Status
Running
EU funding
€2.5m
Total cost
—
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
101247655

What the project is doing

In the project's own words, from its summary on CORDIS.

CroíValve is developing DUO 4 All, a Best-In-Class minimally invasive solution for severe Tricuspid Regurgitation (TR). It is a clear unmet clinical need, with significant impact on mortality, cardiovascular events and quality of life of the large population suffering with this disease. With the highest prevalence of all heart valve diseases, TR is a significant clinical and commercial opportunity. It poses unique challenges in comparison with other heart valve diseases and so needs a solution specifically designed to overcome these challenges.

The CroíValve DUO 4 All Tricuspid Coaptation Valve System is a novel approach that provides the right solution for the right heart. The approach puts both the patient and physician at the centre of the design by ensuring it is safe, effective, can accommodate the range of patient anatomies and is quick to learn and implant.

Topics

Who is involved

OrganisationCityCountryRole
Croivalve LimitedDublinIrelandCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI